Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GLOFITAMAB vs GLYBURIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GLOFITAMAB vs GLYBURIDE: Safety Overview

Metric GLOFITAMAB GLYBURIDE
Total FAERS Reports 1,116 2,143
Deaths Reported 315 283
Death Rate 28.2% 13.2%
Hospitalizations 492 928
Average Patient Age 62.5 yrs 63.9 yrs
% Female Patients 53.2% 54.0%
FDA Approval Date N/A Apr 14, 2016
Manufacturer Genentech, Inc. Teva Pharmaceuticals USA, Inc.
Route INTRAVENOUS ORAL
Marketing Status N/A Discontinued